Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats

References

• Abd-El-Azim H, et al. (2018). Entrapment efficiency of pyridoxine hydrochloride in unilamellar liposomes: experimental versus model-generated data. J Liposome Res 28:1–16.
   PubMed Web of Science ®Google Scholar
• Aboelwafa AA, El-Setouhy DA, Elmeshad AN. (2010). Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design. AAPS Pharmscitech 11:1591–1602.
   PubMed Web of Science ®Google Scholar
• AbuElfadl A, Boughdady M, Meshali M. (2021). New Peceol™/Span™ 60 Niosomes Coated with Chitosan for Candesartan Cilexetil: Perspective Increase in Absolute Bioavailability in Rats. Int J Nanomed 16:5581.
   PubMed Web of Science ®Google Scholar
• Akash M, et al. (2011). Alternate therapy of type 2 diabetes mellitus (T2DM) with Nigella (Ranunculaceae). J Med Plants Res 5:6885–9.
   Web of Science ®Google Scholar
• Akbarzadeh A, et al. (2007). Induction of diabetes by streptozotocin in rats. Indian J Clin Biochem 22:60–64.
   PubMedGoogle Scholar
• Akhilesh D, Anoop V, Rao B. (2011). Formulation and evaluation of gliclazide loaded maltodextrin based proniosomes. International Journal of Research in Pharmaceutical and Biomedical Sciences 2:1582–1589.
   Google Scholar
• Arafa MF, et al. (2017). Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation. J Drug Delivery Sci Technol 38:9–17.
   Web of Science ®Google Scholar
• Attia IA, et al. (2007). Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS Pharmscitech 8:206–212.
   Web of Science ®Google Scholar
• Aziz DE, Abdelbary AA, Elassasy AI. (2018). Implementing central composite design for developing transdermal diacerein-loaded niosomes: ex vivo permeation and in vivo deposition. Current Drug Delivery 15:1330–1342.
   PubMed Web of Science ®Google Scholar
• Azmin M, et al. (1986). The effect of niosomes and polysorbate 80 on the metabolism and excretion of methotrexate in the mouse. J Microencapsulation 3:95–100.
   PubMedGoogle Scholar
• Balakrishnan P, et al. (2009). Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 377:1–8.
   PubMed Web of Science ®Google Scholar
• Bini K, et al. (2012). Development and characterization of non-ionic surfactant vesicles (niosomes) for oral delivery of lornoxicam. International Journal of Drug Development and Research 4:0.
   Google Scholar
• DeFronzo RA, et al. (2015). Type 2 diabetes mellitus. Nat Rev Dis Primers 1:1–22.
   Web of Science ®Google Scholar
• DeFronzo RA. (1999). Pharmacologic therapy for type 2 diabetes mellitus. Annals of Internal Medicine 131:281–303.
   PubMed Web of Science ®Google Scholar
• Devaraj GN, Parakh SR, Devraj R, et al. (2002). Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Colloid Interface Sci 251:360–365.
   PubMed Web of Science ®Google Scholar
• Dziemidowicz K. (2018). Co-processed excipients for dispersible tablets—part 2: patient acceptability. AAPS PharmSciTech 19:2646–2657.
   PubMed Web of Science ®Google Scholar
• Ebrahimi HA, et al. (2016). Development and characterization of a novel lipohydrogel nanocarrier: repaglinide as a lipophilic model drug. J Pharm Pharmacol 68:450–458.
   PubMed Web of Science ®Google Scholar
• Essa EA. (2010). Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian Journal of Pharmaceutics (AJP) 4: 227–233.
   Google Scholar
• Fouad SA, et al. (2018). Novel instantly-dispersible nanocarrier powder system (IDNPs) for intranasal delivery of dapoxetine hydrochloride: in-vitro optimization, ex-vivo permeation studies, and in-vivo evaluation. Drug Dev Ind Pharm 44:1443–1450.
   PubMed Web of Science ®Google Scholar
• Fouad SA, et al. (2020). Development of orally disintegrating tablets containing solid dispersion of a poorly soluble drug for enhanced dissolution: in-vitro optimization/in-vivo evaluation. PLoS One 15:e0244646.
   PubMed Web of Science ®Google Scholar
• Gadadare R, Mandpe L, Pokharkar V. (2015). Ultra rapidly dissolving repaglinide nanosized crystals prepared via bottom-up and top-down approach: influence of food on pharmacokinetics behavior. AAPS PharmSciTech 16:787–799.
   PubMed Web of Science ®Google Scholar
• Gagliardi A, et al. (2020). Design and characterization of glyceryl monooleate-nanostructures containing doxorubicin hydrochloride. Pharmaceutics 12:1017.
   PubMed Web of Science ®Google Scholar
• Gamal M, El Maghraby AA, Ahmed MA. Osman (2015). Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery. Saudi Pharm J 7:67–74. 23
   Google Scholar
• Gohel M, Jogani PD. (2005). A review of co-processed directly compressible excipients. J Pharm Pharm Sci 8:76–93.
   PubMed Web of Science ®Google Scholar
• Guardado-Mendoza R, et al. (2013). State of the art paper The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus. Archives of Medical Science 9:936–43.
   PubMed Web of Science ®Google Scholar
• Gurrapu A, et al. (2012). Improved oral delivery of valsartan from maltodextrin-based proniosome powders. Adv Powder Technol 23:583–90.
   Web of Science ®Google Scholar
• Hasan AA, Madkor H, Wageh S. (2013). Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Delivery 20:120–126.
   PubMed Web of Science ®Google Scholar
• Hatorp V, Huang W-C, Strange P. (1999). Repaglinide pharmacokinetics in healthy young adult and elderly subjects. Clin Ther 21:702–10.
   PubMed Web of Science ®Google Scholar
• Hirani JJ, Rathod DA, Vadalia KR. (2009). Orally disintegrating tablets: a review. Trop J Pharm Res 8:161–172.
   Web of Science ®Google Scholar
• Jadon PS, et al. (2009). Enhanced oral bioavailability of griseofulvin via niosomes. Aaps Pharmscitech 10:1186–1192.
   PubMed Web of Science ®Google Scholar
• Jia P, et al. (2015). Synthesis and characterization of glyceryl monooleate-based polyester. Korean J Chem Eng 32:547–551.
   Web of Science ®Google Scholar
• Kamel AE, Fadel M, Louis D. (2019). Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line. Int J Nanomed 14:5073.
   PubMed Web of Science ®Google Scholar
• Karami Z, et al. (2020). Improved oral bioavailability of repaglinide, a typical BCS Class II drug, with a chitosan‐coated nanoemulsion. J Biomed Mater Res Part B 108:717–28.
   PubMed Web of Science ®Google Scholar
• Khan MI, Madni A, Peltonen L. (2016). Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Eur J Pharm Sci 95:88–95.
   PubMed Web of Science ®Google Scholar
• Krupa A, et al. (2012). The influence of the API properties on the ODTs manufacturing from co-processed excipient systems. AAPS PharmSciTech 13:1120–1129.
   PubMed Web of Science ®Google Scholar
• Malaak FA, et al. (2019). Orodispersible Tablets: Novel Strategies and future challenges in Drug Delivery. Research Journal of Pharmacy and Technology 12:5575–5582.
   Google Scholar
• Mehta SK, Jindal N, Kaur G. (2011). Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes. Colloids Surf, B 87:173–179.
   PubMed Web of Science ®Google Scholar
• Mohamed HB, et al. (2017). Niosomes: a strategy toward prevention of clinically significant drug incompatibilities. Sci Rep 7:1–14.
   PubMed Web of Science ®Google Scholar
• Moqbel HA, ElMeshad AN, El-Nabarawi MA. (2016). A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation. Drug Delivery 23:2998–3007.
   PubMed Web of Science ®Google Scholar
• Namdeo A, et al. (1999). Formulation and evaluation of niosome encapsulated indomethacin. Indian Drugs 36:378–80.
   Google Scholar
• Naresh RR, et al. (1994). Anti-inflammatory activity of niosome encapsulated diclofenac sodium in arthritic rats. Indian Journal of Pharmacology 26:46–8.
   Google Scholar
• Nicolescu C, et al. (2010). Phase solubility studies of the inclusion complexes of repaglinide with β-cyclodextrin and β-cyclodextrin derivatives. Farmacia 58:620–628.
   Web of Science ®Google Scholar
• Ning M, et al. (2005). Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats. Drug Delivery 12:399–407.
   PubMed Web of Science ®Google Scholar
• Nyamweya NN, Kimani SN, Abuga KO. (2020). Chewable Antacid Tablets: Are Disintegration Tests Relevant. AAPS PharmSciTech 21:139. 5,17;22.
   PubMed Web of Science ®Google Scholar
• Olokoba AB, Obateru OA, Olokoba LB. (2012). Type 2 diabetes mellitus: a review of current trends. Oman Medical Journal 27:269.
   PubMedGoogle Scholar
• Pharmacopoeia E. Published by the Directorate for the Quality of Medicines of the Council of Europe (EDQM) by Janssen MP, Behr-Gross ME, (eds.), 2002, Strasbourg, France.
   Google Scholar
• Prajapati ST, Patel PB, Patel CN. (2012). Formulation and evaluation of sublingual tablets containing Sumatriptan succinate. International Journal of Pharmaceutical Investigation 2:162.
   PubMedGoogle Scholar
• Ramadan WM, Singh AP. (2009). Preparation of Acyclovir Loaded Non ionic Surfactant Vesicles (Niosomes) Using Reverse Phase Evaporation Technique. Research Journal of Pharmacy and Technology 2:793–795.
   Google Scholar
• Rehab A, Sammar FE, Nevine SA, et al. (2021). Formulation and Characterization of Acetazo-lamide/Carvedilol Niosomal Gel for Glaucoma Treatment. In Vitro, and in Vivo Study. Pharmaceutics 13:221.
   Google Scholar
• Ruckmani K, Jayakar B, Ghosal S. (2000). Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro release. Drug Dev Ind Pharm 26:217–222.
   PubMed Web of Science ®Google Scholar
• Sachs-Barrable K, et al. (2007). Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells. J Pharm Pharm Sci 10:319–31.
   PubMed Web of Science ®Google Scholar
• Sahoo CK, et al. (2017). Development and evaluation of controlled release formulation of zidovudine based on microporous osmotic tablet technology using fructose as osmogen. Research J. Pharm. and Tech 10:1459–1470.
   Google Scholar
• Schlich M, et al. (2020). Resveratrol proniosomes as a convenient nanoingredient for functional food. Food Chem 310:125950.
   PubMed Web of Science ®Google Scholar
• Scognamiglio I, De Stefano D, Campani V, et al. (2013). Nanocarriers for topical administration of resveratrol: a comparative study. Int J Pharm 440:179–187.
   PubMed Web of Science ®Google Scholar
• Soliman SM, et al. (2016). Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 23 factorial design and in vivo evaluation in rabbits. Drug Delivery 23:1608–1622.
   PubMed Web of Science ®Google Scholar
• Sultan AA, et al. (2016). Colloidal carriers for extended absorption window of furosemide. J Pharm Pharmacol 68:324–332.
   PubMed Web of Science ®Google Scholar
• Tangri P, Khurana S. (2011). Niosomes: Formulation and evaluation. International Journal 2229:7499.
   Google Scholar
• Taskinen S, et al. (2005). C-reactive protein binds to the 3β-OH group of cholesterol in LDL particles. Biochem Biophys Res Commun 329:1208–1216.
   PubMed Web of Science ®Google Scholar
• Thomas L, Viswanad V. (2012). Formulation and optimization of clotrimazole-loaded proniosomal gel using 32 factorial design. Sci Pharm 80:731–748.
   PubMedGoogle Scholar
• Trotta M, et al. (2002). Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 241:319–327.
   PubMed Web of Science ®Google Scholar
• Wei Y, Xie Y, Cai Z, et al. (2021). Interfacial rheology, emulsifying property and emulsion stability of glyceryl monooleate-modified corn fiber gum. Food Chem 343:128416.
   PubMed Web of Science ®Google Scholar
• Yadav JD, et al. (2011). Niosomes: a review. J Pharm Res 4:632–6.
   Google Scholar
• Yaghoobian M, et al. (2020). The impact of surfactant composition and surface charge of niosomes on the oral absorption of repaglinide as a BCS II model drug. Int J Nanomed 15:8767.
   PubMed Web of Science ®Google Scholar
• Zimmet P. (2003). The burden of type 2 diabetes: are we doing enough? Diabetes & Metabolism 29:6S9–6S18.
   PubMed Web of Science ®Google Scholar